Literature DB >> 33277390

Relationship Between Tau and Cognition in the Evolution of Alzheimer's Disease: New Insights from Tau PET.

Jeremy A Tanner1, Gil D Rabinovici2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33277390      PMCID： PMC9364866          DOI： 10.2967/jnumed.120.257824

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   11.082


× No keyword cloud information.
  16 in total

1.  Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.

Authors:  Hanna Cho; Jae Yong Choi; Hye Sun Lee; Jae Hoon Lee; Young Hoon Ryu; Myung Sik Lee; Clifford R Jack; Chul Hyoung Lyoo
Journal:  J Nucl Med       Date:  2019-03-29       Impact factor: 10.057

2.  First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease.

Authors:  Henryk Barthel
Journal:  J Nucl Med       Date:  2020-10       Impact factor: 10.057

3.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2016-03-08       Impact factor: 13.501

Review 4.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

5.  PET Imaging of Tau Deposition in the Aging Human Brain.

Authors:  Michael Schöll; Samuel N Lockhart; Daniel R Schonhaut; James P O'Neil; Mustafa Janabi; Rik Ossenkoppele; Suzanne L Baker; Jacob W Vogel; Jamie Faria; Henry D Schwimmer; Gil D Rabinovici; William J Jagust
Journal:  Neuron       Date:  2016-03-02       Impact factor: 17.173

6.  Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.

Authors:  Daniel Albrecht; A Lisette Isenberg; Joy Stradford; Teresa Monreal; Abhay Sagare; Maricarmen Pachicano; Melanie Sweeney; Arthur Toga; Berislav Zlokovic; Helena Chui; Elizabeth Joe; Lon Schneider; Peter Conti; Kay Jann; Judy Pa
Journal:  J Neurosci       Date:  2020-10-12       Impact factor: 6.167

7.  Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.

Authors:  Alexandre Bejanin; Daniel R Schonhaut; Renaud La Joie; Joel H Kramer; Suzanne L Baker; Natasha Sosa; Nagehan Ayakta; Averill Cantwell; Mustafa Janabi; Mariella Lauriola; James P O'Neil; Maria L Gorno-Tempini; Zachary A Miller; Howard J Rosen; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

8.  Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.

Authors:  Adam S Fleisher; Michael J Pontecorvo; Michael D Devous; Ming Lu; Anupa K Arora; Stephen P Truocchio; Patricia Aldea; Matthew Flitter; Tricia Locascio; Marybeth Devine; Andrew Siderowf; Thomas G Beach; Thomas J Montine; Geidy E Serrano; Craig Curtis; Allison Perrin; Stephen Salloway; Misty Daniel; Charles Wellman; Abhinay D Joshi; David J Irwin; Val J Lowe; William W Seeley; Milos D Ikonomovic; Joseph C Masdeu; Ian Kennedy; Thomas Harris; Michael Navitsky; Sudeepti Southekal; Mark A Mintun
Journal:  JAMA Neurol       Date:  2020-07-01       Impact factor: 18.302

9.  Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET.

Authors:  Renaud La Joie; Adrienne V Visani; Suzanne L Baker; Jesse A Brown; Viktoriya Bourakova; Jungho Cha; Kiran Chaudhary; Lauren Edwards; Leonardo Iaccarino; Mustafa Janabi; Orit H Lesman-Segev; Zachary A Miller; David C Perry; James P O'Neil; Julie Pham; Julio C Rojas; Howard J Rosen; William W Seeley; Richard M Tsai; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Sci Transl Med       Date:  2020-01-01       Impact factor: 17.956

10.  Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.

Authors:  Michael J Pontecorvo; Michael D Devous; Michael Navitsky; Ming Lu; Stephen Salloway; Frederick W Schaerf; Danna Jennings; Anupa K Arora; Anne McGeehan; Nathaniel C Lim; Hui Xiong; Abhinay D Joshi; Andrew Siderowf; Mark A Mintun
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501
View more
  7 in total

Review 1.  Deep Learning-Based Diagnosis of Alzheimer's Disease.

Authors:  Tausifa Jan Saleem; Syed Rameem Zahra; Fan Wu; Ahmed Alwakeel; Mohammed Alwakeel; Fathe Jeribi; Mohammad Hijji
Journal:  J Pers Med       Date:  2022-05-18

2.  An Item Response Theory Analysis of the Wisconsin Card Sorting Test in Normal Aging, Alzheimer's Disease and Parkinson's Disease: Neurophysiological Approach.

Authors:  Juan Luis Sánchez-Rodríguez; Raúl Juárez-Vela; Iván Santolalla-Arnedo; Regina Ruiz de Viñaspre-Hernandez; Juan Luis Sánchez-González
Journal:  J Pers Med       Date:  2022-03-29

Review 3.  Identifying degenerative effects of repetitive head trauma with neuroimaging: a clinically-oriented review.

Authors:  Breton M Asken; Gil D Rabinovici
Journal:  Acta Neuropathol Commun       Date:  2021-05-22       Impact factor: 7.801

4.  Deep learning improves utility of tau PET in the study of Alzheimer's disease.

Authors:  James Zou; David Park; Aubrey Johnson; Xinyang Feng; Michelle Pardo; Jeanelle France; Zeljko Tomljanovic; Adam M Brickman; Devangere P Devanand; José A Luchsinger; William C Kreisl; Frank A Provenzano
Journal:  Alzheimers Dement (Amst)       Date:  2021-12-31

5.  Role of tau deposition in early cognitive decline in Down syndrome.

Authors:  Sigan L Hartley; Benjamin L Handen; Dana Tudorascu; Laise Lee; Annie Cohen; Brianna Piro-Gambetti; Matthew Zammit; William Klunk; Charles Laymon; Shahid Zaman; Beau M Ances; Marwan Sabbagh; Bradley T Christian
Journal:  Alzheimers Dement (Amst)       Date:  2022-04-01

Review 6.  Imaging Clinical Subtypes and Associated Brain Networks in Alzheimer's Disease.

Authors:  Karl Herholz
Journal:  Brain Sci       Date:  2022-01-23

Review 7.  Dissecting the clinical heterogeneity of early-onset Alzheimer's disease.

Authors:  Daniel W Sirkis; Luke W Bonham; Taylor P Johnson; Renaud La Joie; Jennifer S Yokoyama
Journal:  Mol Psychiatry       Date:  2022-04-07       Impact factor: 13.437
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.